DK0701455T3 - Plasmalignende opløsning - Google Patents

Plasmalignende opløsning

Info

Publication number
DK0701455T3
DK0701455T3 DK94919352T DK94919352T DK0701455T3 DK 0701455 T3 DK0701455 T3 DK 0701455T3 DK 94919352 T DK94919352 T DK 94919352T DK 94919352 T DK94919352 T DK 94919352T DK 0701455 T3 DK0701455 T3 DK 0701455T3
Authority
DK
Denmark
Prior art keywords
solution
plasma
disclosed
dextran
administration
Prior art date
Application number
DK94919352T
Other languages
Danish (da)
English (en)
Inventor
Paul E Segall
Hal Sternberg
Harold D Waitz
Judith M Segall
Original Assignee
Biotime Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26752331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0701455(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/071,533 external-priority patent/US5407428A/en
Application filed by Biotime Inc filed Critical Biotime Inc
Application granted granted Critical
Publication of DK0701455T3 publication Critical patent/DK0701455T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0278—Physical preservation processes
    • A01N1/0284—Temperature processes, i.e. using a designated change in temperature over time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK94919352T 1993-06-04 1994-06-03 Plasmalignende opløsning DK0701455T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/071,533 US5407428A (en) 1993-06-04 1993-06-04 Solutions for use as plasma expanders and substitutes
US13352793A 1993-10-07 1993-10-07
PCT/US1994/006279 WO1994028950A1 (en) 1993-06-04 1994-06-03 Plasma-like solution

Publications (1)

Publication Number Publication Date
DK0701455T3 true DK0701455T3 (da) 2001-06-18

Family

ID=26752331

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94919352T DK0701455T3 (da) 1993-06-04 1994-06-03 Plasmalignende opløsning

Country Status (17)

Country Link
US (14) US5702880A (ru)
EP (1) EP0701455B1 (ru)
JP (1) JP3715312B2 (ru)
KR (1) KR100267604B1 (ru)
CN (1) CN1102851C (ru)
AT (1) ATE199626T1 (ru)
AU (1) AU681675B2 (ru)
BR (1) BR9406742A (ru)
CA (1) CA2164321C (ru)
DE (1) DE69426879T2 (ru)
DK (1) DK0701455T3 (ru)
ES (1) ES2157260T3 (ru)
GR (1) GR3036013T3 (ru)
HK (1) HK1010698A1 (ru)
PT (1) PT701455E (ru)
RU (1) RU2142282C1 (ru)
WO (1) WO1994028950A1 (ru)

Families Citing this family (136)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680305B1 (en) 1993-06-04 2004-01-20 Biotime, Inc. Physiologically acceptable aqueous solutions and methods for their use
US6300322B1 (en) * 1993-06-04 2001-10-09 Biotime, Inc. Plasma-like solution
US5945272A (en) * 1993-06-04 1999-08-31 Biotime, Incorporated Plasma expanders and blood substitutes
US6627393B2 (en) * 1993-06-04 2003-09-30 Biotime, Inc. Solutions for use as plasma expanders and substitutes
EP0701455B1 (en) * 1993-06-04 2001-03-14 Biotime, Inc. Plasma-like solution
US6218099B1 (en) * 1994-06-03 2001-04-17 Biotime, Inc. Methods and compositions for use in perfusion applications
US6040132A (en) * 1996-06-14 2000-03-21 Biostore New Zealand, Ltd. Methods for the lyophilization of living biological materials
US6060233A (en) * 1996-06-14 2000-05-09 Biostore New Zealand, Ltd Methods for the lyophilization of platelets, platelet membranes or erythrocytes
US5827640A (en) * 1996-06-14 1998-10-27 Biostore New Zealand Limited Methods for the preservation of cells and tissues using trimethylamine oxide or betaine with raffinose or trehalose
US6387069B1 (en) * 1996-09-23 2002-05-14 Dsu Medical Corporation Blood set priming method and apparatus
US7166084B2 (en) * 1996-09-23 2007-01-23 Dsu Medical Corporation Blood set priming method and apparatus
US5804551A (en) * 1996-11-12 1998-09-08 Baxter International Inc. Pretraumatic use of hemoglobin
US5814601A (en) * 1997-02-28 1998-09-29 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
US6054427A (en) * 1997-02-28 2000-04-25 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
WO1998041156A1 (en) * 1997-03-17 1998-09-24 Boris Rubinsky The use of cryoprotective agent compounds during cryosurgery
US5834178C1 (en) * 1997-07-09 2002-04-23 Univ Wayne State Flush-storage solution for donor organs
US8409846B2 (en) 1997-09-23 2013-04-02 The United States Of America As Represented By The Department Of Veteran Affairs Compositions, methods and devices for maintaining an organ
US6117166A (en) * 1997-10-27 2000-09-12 Winston; Thomas R. Apparatus and methods for grafting blood vessel tissue
UA72449C2 (en) * 1997-10-31 2005-03-15 Physiologically acceptable aqueous solutions and methods for their use
CN1068778C (zh) * 1998-05-15 2001-07-25 赵超英 救治用的药物组合物及其制备方法
CA2352376C (en) * 1998-11-25 2009-12-22 William F. Aftoora Liquefied water soluble acidity-reducing formulation for food and beverage products
US6706309B1 (en) 1998-11-25 2004-03-16 William F. Aftoora Liquefied water soluble acidity-reducing formulation for food and beverage products
US6589223B1 (en) * 1999-02-03 2003-07-08 Biotime, Inc. Method and compositions for use in perfusion applications
US6755811B1 (en) * 1999-08-25 2004-06-29 Corazon Technologies, Inc. Methods and devices for reducing the mineral content of a region of non-intimal vascular tissue
US6846842B2 (en) 1999-10-07 2005-01-25 Beth Israel Deconess Medical Center, Inc. Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
US6759230B1 (en) * 1999-10-26 2004-07-06 The Board Of Regents, The University Of Texas Microbe, microbial exopolysaccharide, and uses thereof
US6492103B1 (en) * 2000-01-31 2002-12-10 Organ Recovery Systems, Inc. System for organ and tissue preservation and hypothermic blood substitution
US8632785B2 (en) * 2000-02-08 2014-01-21 Allergan, Inc. Clostridial toxin pharmaceutical composition containing a gelatin fragment
CA2494241C (en) * 2000-02-08 2011-06-14 Allergan, Inc. Botulinum toxin pharmaceutical compositions
US20030118598A1 (en) * 2000-02-08 2003-06-26 Allergan, Inc. Clostridial toxin pharmaceutical compositions
US7780967B2 (en) * 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
US20060269575A1 (en) * 2000-02-08 2006-11-30 Allergan, Inc. Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
WO2001078803A1 (en) * 2000-04-14 2001-10-25 Biotime, Inc. Systems, kits, and methods of administering synthetic plasma
AU2001279073B2 (en) * 2000-07-28 2006-08-24 Christopher J. Murphy Transplant media
AU2002214443B2 (en) 2000-11-03 2005-12-15 Vitrolife Ab Evaluation and preservation solution
US6746836B1 (en) * 2000-12-08 2004-06-08 Abe Widra Alpha-keratose as a blood plasma expander and use thereof
US6864231B2 (en) * 2001-01-09 2005-03-08 Pharmachem Laboratories, Inc. Glycoprotein matrix compositions and methods related thereto
US6806069B2 (en) 2001-01-09 2004-10-19 Pharmachem Laboratories, Inc. Ubiquinone composition and methods related thereto
EP1377339A4 (en) * 2001-04-04 2006-05-31 Critical Therapeutics Inc PROCEDURE FOR PREVENTING AKUTER NIERENINSUFFIZIENZ
AU2002312458A1 (en) * 2001-06-11 2002-12-23 Fred Hutchinson Cancer Research Center Methods for inducing reversible stasis
US20070213793A1 (en) * 2001-08-06 2007-09-13 Radiant Medical, Inc. Use of endovascular hypothermia in organ and/or tissue transplantations
US20070160645A1 (en) * 2001-10-25 2007-07-12 Jakob Vinten-Johansen PostConditioning System And Method For The Reduction Of Ischemic-Reperfusion Injury In The Heart And Other Organs
EP1438085B1 (en) 2001-10-25 2008-10-15 Emory University Catheter for modified perfusion
US20050164915A1 (en) * 2002-04-01 2005-07-28 Sangart, Inc. Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US20030216470A1 (en) * 2002-04-17 2003-11-20 Fink Mitchell P. Method for treating ileus
JP3912206B2 (ja) * 2002-07-05 2007-05-09 株式会社日立製作所 筒内直接燃料噴射装置用燃料ポンプ
WO2004069371A1 (ja) * 2003-02-04 2004-08-19 National Institute Of Advanced Industrial Science And Technology 塩の水溶液から不純物含有量を低減する方法
CA2523740C (en) * 2003-05-01 2012-05-15 Innogene Kalbiotech Pte Ltd Lactate containing pharmaceutical composition and uses thereof
JP2007525588A (ja) * 2004-03-01 2007-09-06 ベー・ブラウン・メルズンゲン・アクチエンゲゼルシャフト ヒドロキシエチルデンプン
GB0407583D0 (en) * 2004-04-05 2004-05-05 Arbab Tarig S M Diagnostic testing and related matters
WO2007001339A2 (en) * 2004-08-17 2007-01-04 Wake Forest University Health Sciences Ambient stored blood plasma expanders
US8304181B2 (en) * 2004-10-07 2012-11-06 Transmedics, Inc. Method for ex-vivo organ care and for using lactate as an indication of donor organ status
US9301519B2 (en) 2004-10-07 2016-04-05 Transmedics, Inc. Systems and methods for ex-vivo organ care
CA2584066C (en) 2004-10-07 2018-01-23 Transmedics, Inc. Systems and methods for ex-vivo organ care
JP2008525468A (ja) * 2004-12-22 2008-07-17 エモリー・ユニバーシティ ポストコンディショニング臓器保護作用を増強する治療補助薬
EP1868430B1 (en) * 2005-04-12 2015-07-08 Cleo Cosmetic and Pharmaceutical Co., LLC Composition and method for in vitro preservation of corneal tissues
ES2443653T3 (es) * 2005-04-20 2014-02-20 Fred Hutchinson Cancer Research Center Procedimientos, composiciones y artículos de fabricación para mejorar la supervivencia de células, tejidos, órganos y organismos
US9078428B2 (en) * 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
KR101119847B1 (ko) * 2005-11-08 2012-03-14 아지노모토 가부시키가이샤 마취 각성 촉진제
US7854754B2 (en) 2006-02-22 2010-12-21 Zeltiq Aesthetics, Inc. Cooling device for removing heat from subcutaneous lipid-rich cells
AU2006341414A1 (en) * 2006-04-03 2007-10-11 Innogene Kalbiotech Pte Ltd Lactate and calcium containing pharmaceutical composition and uses thereof
ES2625850T3 (es) 2006-04-19 2017-07-20 Transmedics, Inc. Procedimientos para el cuidado de órganos ex vivo
US8192474B2 (en) 2006-09-26 2012-06-05 Zeltiq Aesthetics, Inc. Tissue treatment methods
US20080077201A1 (en) 2006-09-26 2008-03-27 Juniper Medical, Inc. Cooling devices with flexible sensors
US9132031B2 (en) 2006-09-26 2015-09-15 Zeltiq Aesthetics, Inc. Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
US20080287839A1 (en) 2007-05-18 2008-11-20 Juniper Medical, Inc. Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator
GB0712833D0 (en) * 2007-07-03 2007-08-08 Aqix Ltd Body Fluid Expander
US8523927B2 (en) 2007-07-13 2013-09-03 Zeltiq Aesthetics, Inc. System for treating lipid-rich regions
WO2009026471A1 (en) 2007-08-21 2009-02-26 Zeltiq Aesthetics, Inc. Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue
US20090123436A1 (en) * 2007-11-08 2009-05-14 Surmodics, Inc. Cryopreservative compositions and methods
US10750738B2 (en) 2008-01-31 2020-08-25 Transmedics, Inc. Systems and methods for ex vivo lung care
US20090263780A1 (en) * 2008-04-17 2009-10-22 Yanming Wang Organ preservation fluid
EP2346428B1 (en) 2008-09-25 2019-11-06 Zeltiq Aesthetics, Inc. Treatment planning systems and methods for body contouring applications
US8603073B2 (en) 2008-12-17 2013-12-10 Zeltiq Aesthetics, Inc. Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
CN101444526B (zh) * 2008-12-30 2012-06-27 杭州民生药业有限公司 一种药物组合物
US8702774B2 (en) 2009-04-30 2014-04-22 Zeltiq Aesthetics, Inc. Device, system and method of removing heat from subcutaneous lipid-rich cells
SE534527C2 (sv) * 2009-09-24 2011-09-20 Vivoline Medical Ab Förfarande, anordning och vätska för behandling av ett hjärta efter uttagning
DE102009045589A1 (de) * 2009-10-12 2011-04-14 Universitätsklinikum Freiburg Vorrichtung zur Behandlung eines Individuums mit Herzminderleistung, Herzstillstand oder Schlaganfall
BR112012018521A2 (pt) 2010-01-25 2019-09-24 Zeltiq Aesthetics Inc aplicadores para uso doméstico para remover de forma não invasiva calor de células subcutâneas ricas em lipídeos por meio de refrigerantes de mudança de fase, e dispositivos, sistemas e métodos associados
WO2011160012A1 (en) * 2010-06-17 2011-12-22 The Trustees Of Columbia University In The City Of New York Tissue culture media containing trimethylamine n-oxide
US8676338B2 (en) 2010-07-20 2014-03-18 Zeltiq Aesthetics, Inc. Combined modality treatment systems, methods and apparatus for body contouring applications
IT1401386B1 (it) * 2010-07-30 2013-07-18 Eurotech S P A Dispositivo di raffreddamento a liquido per schede elettroniche, in particolare per unita' di elaborazione ad elevate prestazioni
GB201020300D0 (en) 2010-11-30 2011-01-12 Vitrolife Sweden Ab Product
WO2012103242A1 (en) 2011-01-25 2012-08-02 Zeltiq Aesthetics, Inc. Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells
US8828710B2 (en) 2011-03-15 2014-09-09 Paragonix Technologies, Inc. System for hypothermic transport of samples
CA2830225C (en) 2011-03-15 2020-03-24 Paragonix Technologies, Inc. Apparatus for oxygenation and perfusion of tissue for organ preservation
US9253976B2 (en) 2011-03-15 2016-02-09 Paragonix Technologies, Inc. Methods and devices for preserving tissues
US11178866B2 (en) 2011-03-15 2021-11-23 Paragonix Technologies, Inc. System for hypothermic transport of samples
US9867368B2 (en) 2011-03-15 2018-01-16 Paragonix Technologies, Inc. System for hypothermic transport of samples
US9426979B2 (en) 2011-03-15 2016-08-30 Paragonix Technologies, Inc. Apparatus for oxygenation and perfusion of tissue for organ preservation
DK2704560T3 (da) 2011-04-14 2022-05-23 Transmedics Inc Organbehandlingsopløsning til maskinperfusion ex-vivo af donorlunger
CN102488942B (zh) * 2011-11-22 2013-03-20 安徽双鹤药业有限责任公司 回血试验方法及其回血试验装置
US20130330706A1 (en) * 2012-06-06 2013-12-12 Evan C. Unger Fluid for Suspended Animation
US8785116B2 (en) 2012-08-10 2014-07-22 Paragonix Technologies, Inc. Methods for evaluating the suitability of an organ for transplant
US9560846B2 (en) 2012-08-10 2017-02-07 Paragonix Technologies, Inc. System for hypothermic transport of biological samples
US9844460B2 (en) 2013-03-14 2017-12-19 Zeltiq Aesthetics, Inc. Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same
US9545523B2 (en) 2013-03-14 2017-01-17 Zeltiq Aesthetics, Inc. Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue
WO2015117036A2 (en) 2014-01-30 2015-08-06 Zeltiq Aesthetics, Inc. Treatment systems, methods, and apparatuses for improving the appearance of skin and providing for other treatments
US10675176B1 (en) 2014-03-19 2020-06-09 Zeltiq Aesthetics, Inc. Treatment systems, devices, and methods for cooling targeted tissue
USD777338S1 (en) 2014-03-20 2017-01-24 Zeltiq Aesthetics, Inc. Cryotherapy applicator for cooling tissue
US10952891B1 (en) 2014-05-13 2021-03-23 Zeltiq Aesthetics, Inc. Treatment systems with adjustable gap applicators and methods for cooling tissue
EP3151663B1 (en) 2014-06-02 2020-09-23 Transmedics, Inc. Ex vivo organ care system
US10568759B2 (en) 2014-08-19 2020-02-25 Zeltiq Aesthetics, Inc. Treatment systems, small volume applicators, and methods for treating submental tissue
US10935174B2 (en) 2014-08-19 2021-03-02 Zeltiq Aesthetics, Inc. Stress relief couplings for cryotherapy apparatuses
EP3229588A4 (en) 2014-12-12 2019-03-13 Freed, Darren APPARATUS AND METHOD FOR ORGAN PERFUSION
US20180169139A1 (en) * 2015-06-10 2018-06-21 Cellphire, Inc. Composition and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia
KR102411018B1 (ko) 2015-08-18 2022-06-20 아스텔라스 인스티튜트 포 리제너러티브 메디슨 임상 제제
JP6934005B2 (ja) 2015-09-09 2021-09-08 トランスメディクス，インコーポレイテッド エキソビボ臓器管理システムのための大動脈カニューレ
US10448631B2 (en) 2015-09-22 2019-10-22 East Carolina University Cryopreservation using sucralose
WO2017070112A1 (en) 2015-10-19 2017-04-27 Zeltiq Aesthetics, Inc. Vascular treatment systems, cooling devices, and methods for cooling vascular structures
AU2017206118B2 (en) 2016-01-07 2021-09-30 Zeltiq Aesthetics, Inc. Temperature-dependent adhesion between applicator and skin during cooling of tissue
US10765552B2 (en) 2016-02-18 2020-09-08 Zeltiq Aesthetics, Inc. Cooling cup applicators with contoured heads and liner assemblies
CN106092848B (zh) * 2016-03-22 2018-07-06 威海威高血液净化制品有限公司 透析器超滤性能测试液
US11382790B2 (en) 2016-05-10 2022-07-12 Zeltiq Aesthetics, Inc. Skin freezing systems for treating acne and skin conditions
US10555831B2 (en) 2016-05-10 2020-02-11 Zeltiq Aesthetics, Inc. Hydrogel substances and methods of cryotherapy
US10682297B2 (en) 2016-05-10 2020-06-16 Zeltiq Aesthetics, Inc. Liposomes, emulsions, and methods for cryotherapy
US10426796B2 (en) 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
ES2651717B1 (es) * 2016-07-26 2018-11-16 Lara OLLER DUQUE Solución acuosa cristaloide isotónica
WO2018106250A1 (en) * 2016-12-08 2018-06-14 Cellphire, Inc. Compositions and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia
US11076879B2 (en) 2017-04-26 2021-08-03 Zeltiq Aesthetics, Inc. Shallow surface cryotherapy applicators and related technology
WO2018226993A1 (en) 2017-06-07 2018-12-13 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
WO2020028472A1 (en) 2018-07-31 2020-02-06 Zeltiq Aesthetics, Inc. Methods, devices, and systems for improving skin characteristics
EP3886879A4 (en) 2018-11-30 2022-12-07 Cellphire Inc. PLATES AS DELIVERY AGENTS
WO2020113090A1 (en) 2018-11-30 2020-06-04 Cellphire, Inc. Platelets as delivery agents
US11998564B2 (en) 2018-12-14 2024-06-04 National Taiwan University Stable cardioplegic solution for cardiac surgery
AU2020267368B2 (en) 2019-05-03 2023-05-04 Cellphire, Inc. Materials and methods for producing blood products
CA3139053A1 (en) 2019-06-03 2020-12-10 Cooler Heads Care, Inc. Cooling cap assembly and cooling unit
WO2021034719A1 (en) 2019-08-16 2021-02-25 Cellphire, Inc. Thrombosomes as an antiplatelet agent reversal agent
US11632951B2 (en) 2020-01-31 2023-04-25 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
WO2021158622A1 (en) 2020-02-04 2021-08-12 Cellphire, Inc. Anti-fibrinolytic loaded platelets
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
IT202000027050A1 (it) * 2020-11-12 2022-05-12 S A L F S P A Laboratorio Farm Soluzione colloidale per la perfusione e la conservazione ex-vivo dei polmoni
USD1031028S1 (en) 2022-09-08 2024-06-11 Paragonix Technologies, Inc. Tissue suspension adaptor

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34077A (en) * 1862-01-07 Improvement in weighing-registers
US3356570A (en) * 1964-11-27 1967-12-05 Trustees Of Barnes Hospital Composition for treating shock
US3758382A (en) * 1968-07-26 1973-09-11 Us Navy Ve agent process of freezing blood using a hydroxyalkyl starch as cryoprotecti
ZA702706B (en) * 1969-04-28 1971-12-29 Knox Gelatine Inc Blood plasma substitute
US3897550A (en) * 1971-06-01 1975-07-29 Cybersol Method for administering water soluble drugs, nutrients and other solutes to a mammal
US3937821A (en) * 1971-08-21 1976-02-10 Kyorin Seiyaku Kabushiki Kaisha Plasma substitute including artificial starch and method for the preparation thereof
US3949098A (en) * 1974-06-05 1976-04-06 Nabisco, Inc. Nutritious orange drink concentrate, process and drink resultant therefrom
US4061736A (en) * 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
US4001401A (en) * 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
DE2801123C2 (de) * 1977-01-26 1986-01-02 Armour Pharma GmbH & Co KG, 3440 Eschwege Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
US4609372A (en) * 1983-10-13 1986-09-02 Miles Laboratories, Inc. Heat sterilizable storage solution for red blood cells
AU583272B2 (en) * 1984-04-27 1989-04-27 Synthetic Blood Corporation Coacervate system synthetic whole blood substitute
CA1264442A (en) * 1984-06-22 1990-01-16 Richard L. Veech Electrolyte solutions and in vivo use thereof
US5084377A (en) * 1984-09-19 1992-01-28 Larry Rowan Cryogenic suspension method
US4879283A (en) * 1985-10-03 1989-11-07 Wisconsin Alumni Research Foundation Solution for the preservation of organs
US4908350A (en) * 1985-10-31 1990-03-13 The Regents Of The University Of California Hyperosmotic/hyperoncotic solutions for resuscitation of hypodynamic shock
US4769318A (en) * 1986-06-03 1988-09-06 Ube Industries, Ltd. Additive solution for blood preservation and activation
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
JPS6360931A (ja) * 1986-08-29 1988-03-17 Noboru Sato 血液または血液製剤保存液およびこれを用いた血液または血液製剤の保存方法
US4927806A (en) * 1987-04-23 1990-05-22 The Regents Of The University Of California Saturated salt/concentrated dextran formulation to treat hemorrhage
DE3889547T2 (de) * 1987-12-24 1994-11-17 Borody Thomas J Orthostatische waschlösungen.
US5130230A (en) * 1988-05-02 1992-07-14 Cryomedical Sciences, Inc. Blood substitute
USRE34077E (en) * 1988-05-02 1992-09-22 Cryomedical Sciences, Inc. Blood substitute
US4923442A (en) * 1988-05-02 1990-05-08 Cryomedical Sciences Inc. Blood substitute
JPH03220201A (ja) * 1988-11-18 1991-09-27 Eisai Co Ltd プロスタグランジン類と多糖類の結合体
US5252213A (en) * 1989-06-20 1993-10-12 University Of Washington Dry dialysate composition
US5082831A (en) * 1989-12-05 1992-01-21 Cryovita Laboratories, Inc. Total body washout solution and method of use
US5171526A (en) * 1990-01-05 1992-12-15 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
EP0523037A4 (en) * 1990-03-30 1993-07-28 Biomedical Frontiers, Inc. Fluid resuscitation
US5416078A (en) * 1990-03-30 1995-05-16 Biomedical Frontiers, Inc. Fluid resuscitation
US5248766A (en) * 1990-08-17 1993-09-28 Baxter International Inc. Oxirane-modified hemoglobin based composition
GB9021325D0 (en) * 1990-10-01 1990-11-14 Geistlich Soehne Ag Chemical composition
WO1992008349A1 (en) * 1990-11-07 1992-05-29 Baxter International Inc. Blood platelet storage medium
CA2066374C (en) * 1991-04-19 2002-01-29 Paul E. Segall Solution for perfusing primates
WO1993002653A1 (en) * 1991-08-08 1993-02-18 Segel Leigh D Fluorocarbon blood substitute
EP0701455B1 (en) * 1993-06-04 2001-03-14 Biotime, Inc. Plasma-like solution
US5407428A (en) * 1993-06-04 1995-04-18 Biotime, Inc. Solutions for use as plasma expanders and substitutes

Also Published As

Publication number Publication date
US5747071A (en) 1998-05-05
RU2142282C1 (ru) 1999-12-10
US5723281A (en) 1998-03-03
JPH08511265A (ja) 1996-11-26
US5698536A (en) 1997-12-16
US6080538A (en) 2000-06-27
WO1994028950A1 (en) 1994-12-22
US5733894A (en) 1998-03-31
US6406839B1 (en) 2002-06-18
CA2164321C (en) 2002-08-20
CN1102851C (zh) 2003-03-12
AU7052594A (en) 1995-01-03
US6410218B2 (en) 2002-06-25
DE69426879D1 (de) 2001-04-19
US20020025562A1 (en) 2002-02-28
JP3715312B2 (ja) 2005-11-09
US5571801A (en) 1996-11-05
EP0701455A4 (en) 1998-01-07
CN1127476A (zh) 1996-07-24
US5968726A (en) 1999-10-19
US20020012957A1 (en) 2002-01-31
US6444418B2 (en) 2002-09-03
US5613944A (en) 1997-03-25
AU681675B2 (en) 1997-09-04
ATE199626T1 (de) 2001-03-15
ES2157260T3 (es) 2001-08-16
GR3036013T3 (en) 2001-09-28
US5702880A (en) 1997-12-30
BR9406742A (pt) 1996-03-12
US6110504A (en) 2000-08-29
KR100267604B1 (ko) 2000-11-01
DE69426879T2 (de) 2001-10-18
HK1010698A1 (en) 1999-06-25
US6387612B1 (en) 2002-05-14
US20020009783A1 (en) 2002-01-24
PT701455E (pt) 2001-09-27
CA2164321A1 (en) 1994-12-22
EP0701455B1 (en) 2001-03-14
EP0701455A1 (en) 1996-03-20

Similar Documents

Publication Publication Date Title
DK0701455T3 (da) Plasmalignende opløsning
US7503913B2 (en) Methods and compositions for use in perfusion applications
US5145771A (en) Rinse solution for organs and tissues
KR890009409A (ko) 기관 보존 및 저장에 적당한 조성물 및 기관 보조 방법
US5552267A (en) Solution for prolonged organ preservation
CA2066374A1 (en) Solution for perfusing primates
ATE235813T1 (de) Verfahren zur vorbereitung von organen auf die kryokonservierung
JUDD et al. Cardiac transplantation in mice I. Factors influencing the take and survival of heterotopic grafts
DK0418339T3 (da) Præparat og fremgangsmåde til forebyggelse af sammenvoksninger mellem kropsvæv
KR100855354B1 (ko) 관류세척 보존 용액
PT852491E (pt) Utilizacao de heparinases para diminuir respostas inflamatorias
Hällgren et al. Accumulation of hyaluronan (hyaluronic acid) in myocardial interstitial tissue parallels development of transplantation edema in heart allografts in rats.
Bermudez et al. Oxidative and non-oxidative intracellular killing of Mycobacterium avium complex
HUP9900112A2 (hu) Tartósító oldat
Jönsson et al. Cardiac muscle cell damage induced by restraint stress
EP0551359B1 (en) Chemical compositions
EP0664953B1 (en) Lung graft preservative composition and a method for viable preservation of lung grafts
JPH0822801B2 (ja) 臓器保存用溶液
WO1989010746A3 (en) Blood substitute
Suros et al. Twenty-four-hour preservation of the canine heart
Barner Allogenic vein as a conduit for coronary artery bypass
JPH11246301A (ja) 臓器保存溶液
Fujinami et al. Fibrinolytic activity of the endothelium
BG104385A (en) Physiologically acceptable aqueous solutions and methods for their application
Sułowicz et al. Peroxidase activity in peritoneal macrophages of patients with terminal renal failure treated by intermittent peritoneal dialysis